The dynamic regulation of blood flow in the peripheral circulation comprises multiple mechanisms that work in concert to provide adequate control of blood supply to the various vascular beds that feed organ systems. Blood vessels actively respond to different stimuli to adapt vessel diameter according to the continuously changing metabolic requirements of such organ systems. Among these vasoactive stimuli, shear stress as well as endocrine and paracrine factors play a substantial role in the maintenance of vascular homeostasis and the balance between vasoconstriction and vasodilation by acting on the different cell types that form the vascular wall, such as vascular endothelial and smooth muscle cells (SMCs) ([@bib7]).

Intracellular calcium concentration (\[Ca^2+^\]~i~) is critical for vascular smooth muscle function, as increased \[Ca^2+^\]~i~ triggers SMC contraction. In response to vasoactive ligands that bind to G~q~/phospholipase C--coupled receptors, inositol 1,4,5-trisphosphate (IP~3~) is produced. IP~3~ binds to its receptor (IP~3~R) in the membrane of the SMC SR, which facilitates Ca^2+^ release from the SR, raising \[Ca^2+^\]~i~ and inducing cell contraction. SMCs can also respond to membrane depolarization via voltage-dependent Ca^2+^ channels (VDCCs) that mediate Ca^2+^ entry from the extracellular milieu independently of SR Ca^2+^ release ([@bib14]; [@bib16]), triggering vasoconstriction. Moreover, vascular SMCs express plasma membrane large-conductance, Ca^2+^-activated K^+^ (BK~Ca~) channels, which are gated by Ca^2+^ with relatively low (micromolar) affinity. As a consequence of a large increase in \[Ca^2+^\]~i~ after IP~3~-mediated depletion of internal stores, a BK~Ca~-dependent hyperpolarizing K^+^ current will induce inactivation of VDCCs, thereby preventing vasoconstriction ([@bib7]).

The interplay between the different cellular mechanisms that increase \[Ca^2+^\]~i~ is important for the control of vascular tone. In this context, the report we review here ([@bib17]) sheds an interesting light onto how a negative feedback mechanism involving type 1 IP~3~ receptors (IP~3~R1) and BK~Ca~ channels is established in cerebral artery SMCs. The findings of [@bib17] bring to our attention the possibility that IP~3~ may further regulate vascular tone by increasing the apparent Ca^2+^ sensitivity of the BK~Ca~ channel through a mechanism involving an interaction between the channel and IP~3~R1, independently of SR Ca^2+^ release. Using electrophysiological approaches on freshly isolated cerebral artery SMCs, the authors found that IP~3~ increased the open probability (P~O~) of BK~Ca~ channels in both cell-attached and excised inside-out membrane patches in a dose-dependent manner. Neither fast Ca^2+^ buffering with BAPTA nor elevated pipette Ca^2+^ concentration (2 mM) altered the ability of IP~3~ to increase P~O~ of BK~Ca~ channels, suggesting that the observed phenomenon was independent of both intracellular calcium release and plasma membrane calcium influx. Moreover, when the authors examined the Ca^2+^ sensitivity of BK~Ca~ channels in inside-out patches at a physiological membrane potential of −40 mV, they found that 10 µM IP~3~ induced a decrease of the mean apparent dissociation constant (*K*~d~) for Ca^2+^ of the channel from ∼20 to ∼12 µM.

Other reports have suggested that IP~3~ may regulate vasoconstriction by inducing a direct coupling between IP~3~R1 and canonical transient receptor potential (TRPC) type 3 (TRPC3) channels ([@bib14]; [@bib1]), raising the question of whether IP~3~ regulates BK~Ca~ activity by means of IP~3~R1. Indeed, [@bib17] found that heparin, an IP~3~R blocker as well as a monoclonal antibody against the cytosolic C terminus of IP~3~R1, prevented the IP~3~-mediated increase in BK~Ca~ channel P~O~. Moreover, experiments performed on cerebral artery SMCs isolated from IP~3~R1 knockout mice showed that IP~3~ is unable to increase BK~Ca~ channel P~O~ in the absence of the IP~3~R. This requirement for the IP~3~R suggests that the receptor could interact directly with the BK~Ca~ channel, a hypothesis that was tested by coimmunoprecipitation and immunofluorescence resonance energy transfer (immuno-FRET) studies. Coimmunoprecipitation experiments revealed that both α and β1 subunits of the BK~Ca~ channel are precipitated by an anti-IP~3~R1 antibody, suggesting that the three polypeptides coexist in a higher-order macromolecular complex, whereas immuno-FRET showed that BK~Ca~ and IP~3~R1 localized in close spatial proximity. The data suggest that IP~3~ can modulate vascular tone by regulating BK~Ca~ channel activity independently of the canonical SR Ca^2+^ release pathway, and highlight that this phenomenon requires an interaction between the BK~Ca~ channel and IP~3~R1.

The paper by [@bib17] advances our knowledge of the regulation of vascular function by revealing a novel molecular signaling mechanism for IP~3~, a ubiquitous second messenger that mediates the actions of many G~q~/phospholipase C--coupled vasoconstrictor agonists such as endothelin-1 and angiotensin II ([@bib7]; [@bib1]). The same group has contributed to the understanding of this non-canonical IP~3~ signaling by providing evidence that IP~3~Rs can directly couple to plasma membrane ion channels such as TRPC3, thereby modifying their activity ([@bib14]; [@bib1]). In arterial myocytes, both endothelin-1 and IP~3~ activate a nonselective cation current (*I*~Cat~) that depends on the functional coupling of TRPC3 and IP~3~R1, an interaction that proved to be isoform selective and independent of SR Ca^2+^ release. Although TRPC3-mediated *I*~Cat~ would cause membrane depolarization and activation of VDCCs, thereby inducing vasoconstriction, the novel finding that BK~Ca~ channels are also activated by IP~3~ in an IP~3~R1-dependent manner raises an interesting question regarding the balance between depolarizing and hyperpolarizing currents in arterial myocytes, which could play a significant role in the control of basal vascular tone and of other active vascular processes such as the myogenic response or endothelium-mediated SMC hyperpolarization. In fact, BK~Ca~ channels have been implicated in the control of myogenic tone as a hemodynamic autoregulatory mechanism ([@bib5]), and the fact that IP~3~ is able to simultaneously regulate TRPC3 and BK~Ca~ channels provides insight into the role that paracrine factors may play in the modulation of the myogenic response and the local regulation of blood flow. The role of TRPC channels in the control of vasoconstriction has been addressed before, and it has been suggested that the main isoform involved in the myogenic response (i.e., vasoconstriction in response to increased transmural pressure) is TRPC6, whereas TRPC3 would be implicated in the response to vasoconstrictor agents that elevate IP~3~ ([@bib12]; [@bib1]). Beyond local regulation, it will be interesting to probe the importance of this specific coupling between IP~3~R1 and BK~Ca~ channels in the control of blood flow distribution and its role in other vascular beds.

Despite the compelling evidence discussed above, some questions still remain. For instance, all IP~3~ stimulations in inside-out patch clamp experiments were performed at concentrations of 10 µM IP~3~ or higher, with the support of an IP~3~ dose--response curve that yielded maximal stimulations at 10 µM and an apparent *K*~d~ for IP~3~ of ∼4.1 ± 1.3 µM. Although the authors' discussion about arterial myocyte global \[IP~3~\]~i~ is enlightening, we agree that more accurate measurements of basal and agonist-stimulated arterial myocyte \[IP~3~\]~i~ are required to obtain a clearer picture of the physiologically relevant IP~3~ levels that will induce IP~3~R1-mediated activation of BK~Ca~ channels. To this effect, electrophysiological experiments performed at ∼4 µM IP~3~ (the apparent *K*~d~ indicated by the data) may further clarify the relevance of submaximal IP~3~ levels that may be encountered in a physiological context. It was reported previously that Bt-IP~3~, a cell-permeable IP~3~ analogue, could induce TRPC3-mediated depolarization in endothelium-denuded, SR Ca^2+^-depleted arteries pressurized at 20 mmHg at concentrations as low as 1 µM ([@bib14]), whereas the data provided by [@bib17] show no increase in the mean P~O~ of BK~Ca~ channels at such IP~3~ levels. This discrepancy may be a result of the experimental approach, but we cannot rule out the possibility that the very nature of the interaction between IP~3~R1 and plasma membrane ion channels may be different. IP~3~Rs have multiple IP~3~-binding sites with varying affinities ([@bib4]), and receptor-activating conformational changes induced by IP~3~ binding at different sites could favor interactions with different proteins.

We think that elucidating whether the IP~3~-induced shift in Ca^2+^ sensitivity of the BK~Ca~ channel (from ∼20 to ∼12 µM) is relevant for its biophysical properties, as well as for its physiological role, would be an important step in the clarification of the general picture this paper conveys. However, it remains unsolved whether this effect is in fact a result of a direct molecular interaction between IP~3~R1 and the BK~Ca~ channel. We think that the authors do not provide a conclusive demonstration for the occurrence of a direct interaction, despite that evidence in favor of the requirement of IP~3~R1 for IP~3~-mediated activation of BK~Ca~ channels is presented. Heparin, a general IP~3~R blocker, and an antibody against IP~3~R1 both abolish IP~3~-induced BK~Ca~ activation in inside-out membrane patches. The effect of these IP~3~R1-blocking strategies would require an intact and functional receptor (i.e., able to bind IP~3~ and activate BK~Ca~) excised with the patch. In other work by this group, it was shown that a synthetic peptide corresponding to the N-terminal sequence of the IP~3~R containing the TRPC3-binding region activated a Gd^3+^-sensitive, nonselective cation current (*I*~Cat~). Also, membrane-permeant (TAT-conjugated) synthetic peptides were used to probe the coupling between IP~3~R1 and TRPC3. Data revealed the presence of a calmodulin- and IP~3~R-binding domain in TRPC3 channels that supports the occurrence of the proposed interaction ([@bib1]). To our knowledge, the presence of calmodulin- and IP~3~R-binding domains has not been described in BK~Ca~ channels. The use of these experimental approaches could prove helpful in the validation of the authors' hypothesis by establishing the actual domains that may be mediating the interaction between IP~3~R1 and BK~Ca~ channels.

IP~3~R1 was also shown to localize in close proximity to BK~Ca~ channels by immuno-FRET. As opposed to the standard FRET approach, which makes use of genetically encoded fluorophores directly coupled to the proteins of interest, immuno-FRET is based on the energy transfer between fluorophores coupled to the secondary antibodies of a standard indirect immunofluorescence. In both methodologies, resonance energy transfer occurs between donor and acceptor molecules located within a specific distance (the Förster radius, R~0~) characteristic of each FRET pair, and it is unlikely to occur when the distance between fluorophores is \>100 Å ([@bib8]). Positive immuno-FRET signals are a good indicator of the interaction between IP~3~R1 and BK~Ca~ if the distance between donor and acceptor represents the same separation between these proteins, but this is hard to determine because the three-dimensional structure of the immunocomplex is unknown. Moreover, antibodies are large proteins with a molecular weight of ∼150 kD. Analysis of the crystal structure of various immunoglobulins has shown that the distance between antigen-binding sites can vary between 118 and 185 Å ([@bib9]). Because R~0~ for the FRET pair used by the authors (Cy2/Cy3) is ∼50--60 Å ([@bib17]), it is possible that the actual distance between IP~3~R1 and BK~Ca~ may be \>100 Å, suggesting that energy transfer could be a consequence of the interaction between components of the immunocomplex, regardless of whether or not IP~3~R1 and BK~Ca~ interact and/or localize nearby.

The hypothesis that IP~3~R1 and BK~Ca~ channels are found in close proximity is also supported by coimmunoprecipitation experiments showing that an IP~3~R1 antibody is able to pull down both subunits of the BK~Ca~ channel. Although it is not conclusive evidence of direct interaction, coimmunoprecipitation data clearly suggests the existence of a macromolecular complex that comprises both entities. Despite this attractive inference, [@bib17] do not provide a control reverse immunoprecipitation to strengthen their conclusions. Also, probing the presence of molecular chaperones that may stabilize these interactions could provide insight on the trafficking and signaling properties of the IP~3~R1--BK~Ca~ complex, as well as providing explanation for the intracellular normalized FRET data the authors obtained. However, the fact that the regulatory β1 subunit of the channel was coimmunoprecipitated is particularly important; its role as a crucial regulator of channel activity and Ca^2+^ sensitivity ([@bib3]; [@bib7]) could provide insight on the mechanisms of BK~Ca~ modulation by IP~3~ and IP~3~R1. Experiments aimed at discriminating which BK~Ca~ subunit mediates the interaction between the channel and the IP~3~R or other components of the immunoprecipitated complex will help clarify this issue.

It has been shown previously that TRPC3 and TRPC6 channels can associate with BK~Ca~ channels in differentiated cells of a podocyte cell line ([@bib6]), whereas recent work shows that, in arterial SMCs, caveolin-1, a lipid raft scaffolding protein, assembles IP~3~R1 and TRPC3 channels to signaling complexes ([@bib2]). Moreover, it has been shown that BK~Ca~ channels are localized to lipid rafts in glioma cells, an interaction that places BK~Ca~ channels in close proximity to IP~3~Rs ([@bib11]). The involvement of lipid rafts and caveolin-1 in the architecture of these macromolecular signaling complexes brings a bridging element between the different components that constitute them, and paves the road to further inquiry regarding the physiological role of such complexes and the potential interaction with other elements known to localize to plasma membrane microdomains. However, other potential interactions may take place between plasma membrane ion channels and SR membrane components. The STIM/Orai family of proteins has been shown to mediate store-operated Ca^2+^ entry in many different tissues including vascular smooth muscle, and they have been proposed to interact with members of the TRPC channel family to regulate Ca^2+^ entry at cellular domains where the plasma membrane is in close proximity to the SR membrane ([@bib10]). Therefore, BK~Ca~ channels, IP~3~, and IP~3~Rs may also be subject to interaction with these ion channel families in the control of SMC Ca^2+^ signals, cell contractility, and vascular tone. [Fig. 1](#fig1){ref-type="fig"} summarizes the potential interactions discussed above.

![IP~3~-induced interactions between IP~3~Rs and ion channels in arterial SMCs. Induction of Ca^2+^ release from the SR via IP~3~R (solid orange arrows) is the best-known mechanism of action of IP~3~. Non-canonical IP~3~ signaling is independent of SR Ca^2+^ release and involves an IP~3~-induced interaction of IP~3~R1 with plasma membrane channels such as TRPC3 and BK~Ca~ (red arrowheads), possibly localized in membrane caveolae. TRPC3 activation by IP~3~R1 induces a nonselective cation current (*I*~Cat~; solid green arrow) that depolarizes the cell membrane, activating VDCC and BK~Ca~ channels (dashed green arrows). BK~Ca~ channels are also activated by Ca^2+^ (dashed orange arrows). Whereas VDCCs mediate Ca^2+^ influx through the plasma membrane (purple arrow) leading to contraction, K^+^ efflux through BK~Ca~ channels (blue arrow) leads to hyperpolarization of the cell membrane, which closes VDCCs, leading to SMC relaxation.](JGP_201110607_RGB_Fig1){#fig1}

The evidence regarding the regulation of vascular homeostasis and, in particular, arterial smooth muscle physiology by non-canonical IP~3~ signaling suggests that macromolecular signaling complexes that physically and functionally link the plasma and SR membranes may be an important common theme in terms of the fine modulation of signals that establish vascular SMC excitability and vascular tone, thereby controlling active processes such as the myogenic response. At the same time, they hint at the specific possibility that IP~3~-mediated regulation of BK~Ca~ channels may not only involve the IP~3~R but also other molecules present in these signaling microdomains. The recent determination of the crystal structure of the cytoplasmic Ca^2+^-sensing domain of the BK~Ca~ channels ([@bib13]; [@bib15]) will certainly provide further insight to this matter by means of structure-driven mutational analysis to elucidate the specific regions of BK~Ca~ channels that interact with IP~3~R1. Careful dissection of their components and integration of their independent and interdependent activities in a physiologically sound model of vascular function will be the next step in the advancement of this field.

Please participate in a discussion of this Journal Club article on the *JGP* Facebook page ([www.facebook.com/JGenPhysiol](http://www.facebook.com/topic.php?uid=59647529229&topic=15635)).
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